CEO of Venturecraft Group
Isaac is the founder, CEO, and Principal Partner of Venturecraft Group, a private investment group that provides working capital, clinical validation and regional expansion to growth-stage and late-stage MedTech, BioTech and Digital Health Sectors. It has a regional presence in Asia across Singapore, Malaysia, Hong Kong, China and Taiwan, and operates two incubators located in Singapore (the JTC Launchpad @ one-north) and Hangzhou, China. He is an experienced serial entrepreneur focused on MedTech and ICT startups, and an advisor to several emerging startups and a favored expert speaker on enterprise links between Singapore, Taiwan and China. 

Director of Digital Medine, Center of Biomedical Development Innovation and Incubation, Mackay Memorial Hospital

Aside from leadership for clinical research and development of rapid diagnostic biochips, Dr. Huang has a passion for leveraging information technology to empower patient and healthcare provider. In particular, he is fascinated by mobile and cloud technology on healthcare system. His research team has been awarded funding by the National Science Council for innovating and implementing IT in Education. He currently provides consulting services to many ICT corporate companies, and exploring the subjects using clinical trials as well as data technology in both MacKay Memorial Hospital and MacKay Medical College.

Partner of Cherubic Ventures
Tina is the partner at Cherubic Ventures, an early-stage VC fund with over 100+ portfolio companies in Greater China and the US. Some of the fund's notable investments include Flexport, Wish.com, Pinkoi.Prior to joining Cherubic Ventures, Tina worked as a consultant in Silicon Valley with Fortune 500 companies, and later moved back to Asia to co-found a company that better connects students in emerging markets with education institutions around the world. Tina holds an MBA degree from UCLA Anderson School of Management and a bachelor degree from the College of Communications at National ChengChi University in Taiwan.

CMIO of Global Health Byte Pte Ltd

Melvin is the Chief Medical Information Officer of Global Health Byte a medical tech company based in Singapore with a focus electronic medical records. He also double hats as co-founder of Radiology Advanced, a start-up tele-radiology company based in Berlin and Singapore focusing on radiology services and machine learning applications. As a clinician, Melvin is the Vice President (Operations) of Gleneagles Hospital Singapore, a 258 bed private hospital managed by the Parkway Pantai Group; Asia’s largest hospital operator. Melvin has also help previous appointments as the former executive director and CIO of OneCare Medical, a primary care clinic chain in Singapore and medical director of a medical evacuation company based in South East Asia.

Investment Manager of Hoss Venture

Angela is the investment manager at Hoss Venture, a Taipei-based venture capital office which focus on early stage investments across US and Taiwan. Prior to that she was the manager at CDIB, conducting technology investments in Taiwan and Greater China. Angela received her bachelor and master degree in Biochemical Science and Technology from National Taiwan University.

Managing Director and Founder of Quantum Smile

ShenFu began his career from the financial industry as a tech investment banker, spent 24 years worked with/at American major companies has domain expertise in diverse fields including commercial real estate, healthcare, marketing, and information technology. He served as the investing director of the Solomon Global Holdings Inc., a venture capital firm specializing in growth stage investments. ShenFu is passionate in entrepreneurship and founded several startup companies and successfully led to IPO and M&A. ShengFu has multiple Master degrees in the Computer Science, MBA, and Instructional Design from Columbia University. He also holds a Ph.D. in the field of the Leadership and Organizational Change.

Investment Manager of WK Innovation Fund

Prior to joining WKI, Mike co-founded Toothfilm Inc., an internationally growing biotech startup focusing on oral health and beauty for adults, kids and pets. Before his venture, he served as a product manager at Advantech Corp. after his participation in the founding stage of ICARES Medicus. Mike has been an industry researcher and columnist, he also sits on the advisory board of Girls In Tech Taiwan (an influential headquartered in Silicon Valley) and is the founding chairman of Entrepreneur+, a robust NPO serving young entrepreneurs in Taiwan and the region. He received both bachelor and master degree of Material Science and Engineering from National Cheng Kung University.

Senior Associate of WI Harper

Joyce Lee is a Senior Associate with WI Harper based in the Taipei Office where she focuses on Healthcare, Consumer and Enterprise TMT Sector. Prior to WI Harper, Miss Lee was a Senior Investment Manager with Diamond Biofund, an evergreen healthcare fund with over $ 260 million dollars, where she focused on companies in new drug development, pharmaceutical sector. She successfully lead  investment projects across China and Taiwan. Joyce was an Equity Analyst at Yuanta Securities and covered Healthcare industry. Miss Lee graduated with a Bachelor of Arts degree in Political Science and Economics and an MBA in International Financial Management from National Cheng Kung University.

Director of Global Brand Insights, Philips B.V.

Upon receiving her MBA degree from University of Washington, Seattle, Cortilia Lin worked on a variety of projects including new venture creation and investment raising in the field of medical device.  Her first position at Philips Healthcare was to play the role as an internal consultant via customer insights to strategize marketing plans and customer journey design for more than 30 lines of project across 17 key geographies.  With success, she was recruited for Director of Customer and Brand Intelligence in Amsterdam, where she integrated advanced big data analytics in the customer and brand insights to further support 3-5 year strategic plans.   Employing bioinformatics techniques to enable innovative brand and market entry strategy has become her key strength.